Research map: Nirsevimab and Hospitalization for Lower Respiratory Tract Infection During the Second Season

Back to the article

Papers in this map

  1. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies · Erik B von Elm · 2007 · 20683 citations · Cited by this paper
  2. Nirsevimab Benefits Beyond the First Year After Birth · Cristina Tomatis‐Souverbielle · 2026 · Cites this paper
  3. Trends in Pediatric Hospitalizations Following Interfacility Transfer: 2009–2022 · Sriram Ramgopal · 2026 · 1 citation · Related
  4. Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations · Peter W. G. Tennant · 2020 · 1066 citations · Cited by this paper
  5. Auricular Neurostimulation: A Novel Therapy for Abdominal Pain-Related Disorders of Gut-Brain Interaction · 2026 · Related
  6. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants · Simon B. Drysdale · 2023 · 389 citations · Cited by this paper
  7. Telemedicine Use in Primary Care for Children: 2019–2024 · 2026 · Related
  8. Factors Influencing the Optimal Control-to-Case Ratio in Matched Case-Control Studies · Sean Hennessy · 1999 · 359 citations · Cited by this paper
  9. Hearing-Targeted Congenital Cytomegalovirus Screening: An 11-Year Experience · 2026 · Related
  10. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study · Sonia Ares‐Gómez · 2024 · 259 citations · Cited by this paper
  11. Building the Foundations for Trustworthy AI in Pediatrics · 2026 · Related
  12. Causal Inference About the Effects of Interventions From Observational Studies in Medical Journals · Issa J Dahabreh · 2024 · 229 citations · Cited by this paper
  13. Blood Lead Testing Among Children Enrolled in Medicaid · 2026 · Related
  14. The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis · Lauren C. Ramsay · 2019 · 149 citations · Cited by this paper
  15. Transplant Center Variability and Its Role in US Pediatric Liver Care Inequities · 2026 · Related
  16. Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants · Deidre E. Wilkins · 2023 · 133 citations · Cited by this paper
  17. A Resource to Understand and Prevent Sudden Unexpected Infant Deaths · 2026 · Related
  18. Association Between Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection in Early Life and Recurrent Wheeze and Asthma in Later Childhood · Ting Shi · 2019 · 104 citations · Cited by this paper
  19. Child Welfare System Involvement in the United States: 2016–2023 · 2026 · Related
  20. Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain) · Ermengol Coma · 2024 · 101 citations · Cited by this paper
  21. Early-life respiratory syncytial virus disease and long-term respiratory health · Heather Joy Zar · 2024 · 100 citations · Cited by this paper
  22. How to use directed acyclic graphs: guide for clinical researchers · Timothy Feeney · 2025 · 74 citations · Cited by this paper
  23. Effectiveness and impact of nirsevimab in Chile during the first season of a national immunisation strategy against RSV (NIRSE-CL): a retrospective observational study · Juan Pablo Torres · 2025 · 53 citations · Cited by this paper
  24. Jurisdiction Size and Local Public Health Spending · Rexford E. Santerre · 2009 · 47 citations · Cited by this paper
  25. Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings · Joanne Marie Langley · 2022 · 40 citations · Cited by this paper
  26. The impact of respiratory syncytial virus on asthma development and exacerbation · Ruixue Ma · 2025 · 34 citations · Cited by this paper
  27. A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus · Maarten van Wijhe · 2022 · 33 citations · Cited by this paper
  28. Nirsevimab Effectiveness Against Severe Respiratory Syncytial Virus Infection in the Primary Care Setting · Mónica López‐Lacort · 2024 · 33 citations · Cited by this paper
  29. Respiratory syncytial virus reinfections among infants and young children in the United States, 2011–2019 · Sabina O. Nduaguba · 2023 · 31 citations · Cited by this paper
  30. Effectiveness of nirsevimab introduction against respiratory syncytial virus in the Valencian Community: A preliminary assessment · Pablo Estrella-Porter · 2024 · 30 citations · Cited by this paper
  31. Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012–2013 Through 2017–2018 · Sara S. Kim · 2020 · 29 citations · Cited by this paper
  32. Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case–control study, Spain, 2023/24 season · Olivier G. Nunez · 2025 · 27 citations · Cited by this paper
  33. Lower Respiratory Tract Infections Following Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab Immunization Versus Placebo: Analysis From a Phase 3 Randomized Clinical Trial (MELODY) · Douglas F. Arbetter · 2024 · 23 citations · Cited by this paper
  34. Effectiveness of Nirsevimab Immunoprophylaxis Against Respiratory Syncytial Virus-related Outcomes in Hospital Care Settings: A Seasonal Cohort Study of Infants in Catalonia, Spain · Aida Perramon‐Malavez · 2025 · 22 citations · Cited by this paper
  35. Immunomodulation in Respiratory Syncytial Virus Infection: Mechanisms, Therapeutic Targets, and Clinical Implications · Vasiliki Epameinondas GEORGAKOPOULOU · 2025 · 15 citations · Cited by this paper
  36. Small town growth in the United States: An analysis by size class and by place · Glenn V. Fuguitt · 1966 · 14 citations · Cited by this paper
  37. Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND) · David Moreno Pérez · 2025 · 13 citations · Cited by this paper
  38. Early-life RSV infection modulates innate immune events, preferentially enhancing allergen-induced type 2 lung inflammation in females · Lydia Labrie · 2025 · 7 citations · Cited by this paper
  39. Impact of nirsevimab immunoprophylaxis on respiratory syncytial virus-related outcomes in hospital and primary care after two consecutive seasons: a population-based retrospective cohort study in infants in their second year of life in Catalonia, Spain · Ermengol Coma · 2025 · 7 citations · Cited by this paper

Source: OpenAlex (CC0)